• SE Asia (HQ)

    +65 3158 9910

  • Australia

    1300 798 820

  • New Zealand

    +64 9801 0299

TAILORx trial finds 99 percent of women with low Oncotype DX® Recurrence Score® results are free of breast cancer recurrence after five years of hormone therapy alone